Total Payments
$441,909
2024 Payments
$54,676
Companies
48
Transactions
1,701
Medicare Patients
28,383
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$322,827 (73.1%)
Consulting$39,943 (9.0%)
Food & Beverage$39,442 (8.9%)
Travel$38,956 (8.8%)
Education$742.07 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $321,727 | 150 | 72.8% |
| Consulting Fee | $39,943 | 21 | 9.0% |
| Food and Beverage | $39,442 | 1,409 | 8.9% |
| Travel and Lodging | $38,956 | 108 | 8.8% |
| Honoraria | $1,100 | 2 | 0.2% |
| Education | $742.07 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $120,321 | 138 | $0 (2024) |
| Celgene Corporation | $92,153 | 134 | $0 (2019) |
| PFIZER INC. | $75,193 | 149 | $0 (2024) |
| ABBVIE INC. | $43,356 | 257 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $34,775 | 78 | $0 (2024) |
| Dermavant Sciences, Inc. | $32,020 | 51 | $0 (2024) |
| Promius Pharma LLC | $13,212 | 33 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $4,743 | 80 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $4,660 | 57 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $4,198 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54,676 | 221 | E.R. Squibb & Sons, L.L.C. ($20,947) |
| 2023 | $91,331 | 210 | Amgen Inc. ($36,153) |
| 2022 | $60,933 | 310 | Amgen Inc. ($31,702) |
| 2021 | $42,465 | 245 | Amgen Inc. ($36,335) |
| 2020 | $13,199 | 104 | Amgen Inc. ($10,971) |
| 2019 | $52,367 | 196 | Celgene Corporation ($24,523) |
| 2018 | $40,255 | 174 | PFIZER INC. ($16,634) |
| 2017 | $86,682 | 241 | Celgene Corporation ($51,954) |
All Payment Transactions
1,701 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Immunology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.17 | General |
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 12/02/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation & Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.35 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.56 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $3.65 | General |
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $19.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 10,027 | 17,033 | $1.7M | $765,147 |
| 2022 | 27 | 7,625 | 13,283 | $1.3M | $617,649 |
| 2021 | 24 | 5,218 | 8,472 | $858,914 | $375,595 |
| 2020 | 26 | 5,513 | 8,982 | $874,518 | $397,422 |
Total Patients
28,383
Total Services
47,770
Medicare Billing
$2.2M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,450 | 3,170 | $453,323 | $204,208 | 45.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 1,181 | 1,391 | $228,639 | $102,737 | 44.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,679 | 2,143 | $231,410 | $91,418 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 934 | 934 | $166,314 | $76,033 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 593 | 813 | $164,271 | $74,917 | 45.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 681 | 803 | $147,546 | $70,545 | 47.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,232 | 6,225 | $66,985 | $33,590 | 50.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 131 | 161 | $43,936 | $21,263 | 48.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 299 | 424 | $34,475 | $18,217 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $30,582 | $14,687 | 48.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 237 | 262 | $23,552 | $10,907 | 46.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 60 | $17,280 | $8,554 | 49.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 30 | 32 | $15,661 | $7,146 | 45.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 135 | 135 | $15,519 | $6,996 | 45.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 33 | 36 | $7,120 | $3,361 | 47.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 30 | 32 | $6,520 | $3,341 | 51.2% |
| 69100 | Biopsy of ear | Office | 2023 | 50 | 50 | $7,806 | $3,241 | 41.5% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 20 | 21 | $6,499 | $2,789 | 42.9% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 23 | $5,117 | $2,456 | 48.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 21 | $5,019 | $2,429 | 48.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 23 | 24 | $4,845 | $2,425 | 50.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 16 | 22 | $4,708 | $1,922 | 40.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 29 | 47 | $4,320 | $1,895 | 43.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 88 | $144.55 | $70.73 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 2,059 | 2,591 | $378,364 | $177,231 | 46.8% |
About David Kasper, DO MBA
David Kasper, DO MBA is a Dermatology healthcare provider based in Lansdale, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1811175649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Kasper, DO MBA has received a total of $441,909 in payments from pharmaceutical and medical device companies, with $54,676 received in 2024. These payments were reported across 1,701 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($321,727).
As a Medicare-enrolled provider, Kasper has provided services to 28,383 Medicare beneficiaries, totaling 47,770 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Lansdale, PA
- Active Since 02/04/2008
- Last Updated 04/22/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1811175649
Products in Payments
- Otezla (Drug) $208,822
- EUCRISA (Drug) $62,532
- SKYRIZI (Biological) $39,402
- VTAMA (Drug) $32,020
- Sotyktu (Drug) $21,352
- CIBINQO (Drug) $11,363
- Trianex (Drug) $8,269
- DUPIXENT (Biological) $4,661
- YCANTH (Drug) $4,198
- ILUMYA (Biological) $3,963
- RINVOQ (Biological) $3,095
- Cloderm Cream (Drug) $2,887
- TREMFYA (Drug) $2,419
- Veltin (Drug) $2,383
- Sernivo Spray (Drug) $966.84
- REMICADE (Biological) $926.83
- ENSTILAR (Drug) $787.41
- AKLIEF (Drug) $639.77
- COSENTYX (Biological) $634.56
- Tremfya (Drug) $533.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.